GLIMEPIRIDE : Decreases HbA1c by 1.2-1.9% in patients with type-2 diabetes mellitus,which is not sufficiency controlled by diet & exercise.
METFORMIN HYDROCHLORIDE : Reduces the amount of glucose produced by the liver and preservesthe function of the cells in the pancreas.
PIGOLITAZONE HYDROCHLORIDE : Highly appreciable in diabetic patients with chronic kidney disorder.
SKU-MHAHNQY3JRGLIMEPIRIDE : Decreases HbA1c by 1.2-1.9% in patients with type-2 diabetes mellitus,which is not sufficiency controlled by diet & exercise.
METFORMIN HYDROCHLORIDE : Reduces the amount of glucose produced by the liver and preservesthe function of the cells in the pancreas.
PIGOLITAZONE HYDROCHLORIDE : Highly appreciable in diabetic patients with chronic kidney disorder.